Skip to main content
Clinical Trials/ITMCTR2024000156
ITMCTR2024000156
Not yet recruiting
未知

A randomized controlled study on the analgesic treatment of migraine in acute phase with the combination of horizontal penetration needling and rizatritan

anjing Hospital of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
anjing Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional study
Sex
All

Investigators

Sponsor
anjing Hospital of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Meet the diagnostic criteria of migraine without aura and migraine with aura;
  • 2\) Aged 18\-50 years, with a history of migraine for more than 12 months;
  • 3\) In the acute phase, the pain degree was evaluated by visual analogue scale (VAS) method with 4 points or more;
  • 4\) Patients voluntarily received relevant acute analgesia treatment and signed informed consent.

Exclusion Criteria

  • 1\) Patients with hypertension and current unstable blood pressure control (stage 2, high\-risk patients and above), coronary heart disease (including patients with pacemakers), cerebral infarction and other cardiovascular and cerebrovascular stenosis or obstructive diseases, peripheral vascular stenosis and obstruction;
  • 2\) Patients with severe primary diseases such as liver, kidney, digestion and blood system;
  • 3\) Mental patients, or patients with infection and bleeding;
  • 4\) Pregnant or lactating women;
  • 5\) Patients with organic lesions;
  • 6\) Patients who cannot understand and cooperate with the visual analogue scale (VAS) method.

Outcomes

Primary Outcomes

Not specified

Similar Trials